Dr Ekrem Darendelioglu

Dr. Dr Ekrem Darendelioglu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Acta Histochemica
Verified
Journal Article
Closed access
DDDr Ekrem Darendelioglu
Dr Ekrem Darendelioglu
GAGurkan Aykutoglu
Gurkan Aykutoglu
MTMusa Tartik
Musa Tartik
GBGiyasettin Baydas
Giyasettin Baydas

26 June 2020 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
GAGurkan Aykutoglu
Gurkan Aykutoglu
MTMusa Tartik
Musa Tartik
DDDr Ekrem Darendelioglu
Dr Ekrem Darendelioglu
AAAdnan Ayna
Adnan Ayna
GBGiyasettin Baydas
Giyasettin Baydas

1 August 2016 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
MTMusa Tartik
Musa Tartik
DDDr Ekrem Darendelioglu
Dr Ekrem Darendelioglu
GAGurkan Aykutoglu
Gurkan Aykutoglu
GBGiyasettin Baydas
Giyasettin Baydas

31 December 2021 in TURKISH JOURNAL OF BOTAN
Verified
Journal Article
Closed access
AAAdnan Ayna
Adnan Ayna
ATAbdullah Tunç
Abdullah Tunç
SÖSedanur Özbolat
Sedanur Özbolat
ABAydın Şükrü BENGÜ
Aydın Şükrü BENGÜ
GAGurkan Aykutoglu
Gurkan Aykutoglu
DDDr Ekrem Darendelioglu
Dr Ekrem Darendelioglu

10 February 2020 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
DDDr Ekrem Darendelioglu
Dr Ekrem Darendelioglu

27 November 2024 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
DDDr Ekrem Darendelioglu
Dr Ekrem Darendelioglu
SBSevda SAĞ BAYAV
Sevda SAĞ BAYAV
CCCuneyt Caglayan
Cuneyt Caglayan
Methotrexate (MTX) is a generally applied chemotherapeutic medicine in most cancers treatment. Morin hydrate, a robust antioxidant, is a secondary metabolite observed in numerous plants, along with figs, white mulberries, and others. The hypothesis of this study is that morin hydrate can effectively reduce MTX-induced kidney injury in rats by increasing antioxidant enzyme activity and inhibiting apoptotic processes. This study, 35 male Wistar albino rats were used, and five different experimental groups, each consisting of 7 rats were established. Group 1 served as the control group while Group 2 received morin exclusively via oral administration (at a dose of 100 mg/kg). Group 3, however, was administered MTX exclusively (at a dose of 20 mg/kg). Group 4 received a combination of MTX (20 mg/kg) and morin (50 mg/kg), and Group 5 received a combination of MTX (20 mg/kg) and morin (100 mg/kg). The MTX group showed a significant increase in kidney biomarkers, including serum urea, creatinine, and the lipid peroxidation biomarker MDA, compared to the control group, along with a notable decrease in antioxidant enzyme activity (SOD, CAT, GPx) and GSH levels. Furthermore, MTX notably decreased the expression of procas-3, Bcl-2, procas-9, and procas-8 while concurrently increasing the expression of apoptotic genes such as CYT-C and Bax. Co-administration of morin hydrate with MTX at doses of 50 and 100 mg/kg effectively managed oxidative damage levels and apoptotic markers, demonstrating antioxidant and anti-apoptotic properties. Notably, the 100 mg/kg dose provided more robust protection than the 50 mg/kg dose, indicating a dose-dependent efficacy. This investigation thus supports the conclusion that morin hydrate, at both dosage levels, effectively mitigates MTX-induced renal damage.